Letter to the editor: Long-term safety and efficacy of pegvisomant monotherapy for acromegaly: final data from the full ACROSTUDY cohort

Pituitary 2026

View at publisher
Authors: Neslihan Koray Fedai, İlknur Öztürk Ünsal, Erman Cakal
DOI: 10.1007/s11102-026-01687-5
Cited by: 1
References: 2

Fields of Study & Subjects

Pituitary Gland Disorders and Treatments Autoimmune Neurological Disorders and Treatments Ophthalmology and Eye Disorders

Publication details

Journal / source
Pituitary
Publisher
Springer Science and Business Media LLC
Volume
29
Issue
3
Publication date
6 May 2026
Language
EN